Tom Stossel Attempts to Debunk the Conflict-of-Interest “Myth”
Yesterday, I interviewed Thomas P. Stossel, M.D., visiting scholar at the American Enterprise Institute for Public Policy Research, about his new book, PharmaPhobia, and...
Combatting PharmaPhobia: Conflict-of-Interest Myth Busting
PharmaGuy interviews Thomas P. Stossel, M.D., visiting scholar at the American Enterprise Institute for Public Policy Research, about his new book, PharmaPhobia, and his call to action against the 'Conflict of Interest Movement,' which he claims undermines American medical innovation.
What I Learned During Day 1 at iPharma 2015
I am attending CBI's iPharma 2015 conference in New York City. Yesterday was the first day. I chaired the Technology Track and moderated a...
WANTED: Pharma Mobile Pioneers
For the past few years I have been following and reporting on mobile health initiatives, campaigns, and apps developed by pharmaceutical companies. I've collected...
#Pharma Must Be Social Media Brave & Fast Says Becky Canvin at Ogilvy HealthWorld
"How can the pharma and healthcare industry thrill on social media?"
That's a question Rebecca Canvin (@BeckyCanvin), Social Media Manager at Ogilvy Healthworld, attempted to...
PharmaGuy – the Book! “Socialize Your Patient Engagement Strategy”: Coming This August
How Social Media and Mobile Apps Can Boost Health Outcomes
Letizia Affinito and John Mack
I am happy to announce my collaboration with Letizia Affinito (@laffinito)...
Doling Out Dough to Docs: Types of Payments Pharma* Made to Physicians in 2013,...
Click on image for an enlarged view.
On September 30, 2014, CMS published data records containing 4.4 million payments valued at nearly $3.7 billion in...
Pharma Buzzwords Heard During a Conference
Pharma marketers cannot communicate with each other without using "buzzwords." Some critics suggest, however, that some of these buzzwords alienate patients and physicians (see,...
A Facetious Version of WebMD’s Dr. OZ Style Kybella FAQ
The following facetious FAQ list is based on a WebMD FAQ list ("Here’s what you need to know" about a "New Drug Zaps...
The Patients Included Initiative & Pharma: Pharma Should Offer Continuing Patient Education Grants
One of the guidelines of the Patients Included charter requires scholarships for patient to attend medical and pharma industry conferences. But who will pay the way for patients to attend and how will the scholarships be administered? This article discusses that issue and suggests that the pharmaceutical industry, which claims to be 'patient centric,' can play a role by sponsoring Patients Included scholarships similar to how they sponsor physician continuing medical education programs for physicians.
